Publications
Sargis, RM; Wollmann, RL; Pytel, P. 2009. A 59-year-old man with sellar mass lesion. Brain Pathology, 19: 161-162.
Sargis, RM and Subbaiah, PV. 2006. Sphingomyelin protects membrane cholesterol against free radical-mediated oxidation. Free Radical Biology and Medicine, 40: 2092-2102.
Sargis, RM and Subbaiah, PV. 2003. Trans Unsaturated Fatty Acids are Less Oxidizable than Cis Unsaturated Fatty Acids and Protect Endogenous Lipids from Oxidation in Lipoproteins and Lipid Bilayers. Biochemistry. 42: 11533-11543.
Subbaiah, PV and Sargis, RM. 2001. Sphingomyelin: a natural modulator of membrane homeostasis and inflammation. Medical Hypotheses, 57: 135-138.
Reviews
Sargis, RM. “Arteriosclerosis.” Salkind, N. Ed. Encyclopedia of Human Development. Thousand Oaks, California: Sage Publications, 2005. 115-116.
Abstracts and Presentations
Sargis, RM; Johnson, DN; and Brady, MJ. 2008. Effects of Endocrine Disrupting Chemicals on Adipocyte Metabolism. Abstract for poster presentation, University of Chicago Department of Medicine Research Day, Chicago, IL.
Sargis, RM and Subbaiah, PV. 2006. Sphingomyelin protects membrane cholesterol against free radical-mediated oxidation. Abstract for poster presentation, University of Chicago Department of Medicine Research Day, Chicago, IL.
Sargis, RM and Subbaiah, PV. 2003. Trans Unsaturated Fatty Acids (TUFA) Inhibit Lipid Peroxidation in Lipoproteins and Artificial Membranes. Experimental Biology 2003. FASEB Journal, 17: A748.
Sargis, RM and Subbaiah, PV. 2002. Effect of Trans Unsaturation on the Oxidizability of Membrane Phospholipids. Third Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology, Salt Lake City, UT. Arteriosclerosis, Thrombosis, and Vascular Biology, 22: 878.
